Scientific work

Prof. Dr. Cafer Adıgüzel

142 publications. The source of the information is stated next to each publication.

Back to profile

  1. Increased Antithrombotic And Bleeding Effects Of Contaminated Heparins; Hematological Implications”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-385, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)

    Source: medicana.com.tr profile page

  2. B17. Walenga, J., C. Adiguzel ,J. Cunanan, D. Hoppensteadt, O. Iqbal ve M. Bakhos. “

    Source: medicana.com.tr profile page

  3. Fibrin Clot Formation Differs In The Presence Of Branded And Generic Enoxaparins”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-387, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)

    Source: medicana.com.tr profile page

  4. B18. Hoppensteadt, D., O. Iqbal, C. Adiguzel, J. Cunanan ve J. Fareed. “

    Source: medicana.com.tr profile page

  5. Upregulation Of Procalcitonin In Cancer Patients With Venous Thrombosis”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-482, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)

    Source: medicana.com.tr profile page

  6. B19. Iqbal, O., C. Adiguzel, J. Fareed, D. Hoppensteadt, E. Litinas, H. Zhu, ve A Halaris. “Selective Serotonin Reuptake Inhibitors Influence Agonist-Induced Platelet Aggregation. Preliminary Results from Comorbidity of Depression and Cardiovascular Disease Study”. Blood, 112, 4556, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source: medicana.com.tr profile page

  7. B20. Bansal, V., J. Cunanan, C. Adiguzel, E. Litinas, K. Nelson, ve J. Fareed. A Higher “Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin”. Blood, 112, 3022, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008).

    Source: medicana.com.tr profile page

  8. B21. Zhu, H., D. Hoppensteadt, R. L. Bick, C. Adiguzel, R. Wahi ve Jawed Fareed. “Relative Immunologic Potential of Bovine Prothrombin and Purified Thrombins”. Blood 112, 5463, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source: medicana.com.tr profile page

  9. B22. Fareed, J., D. Hoppensteadt, W. Jeske, C. Adiguzel, O. Iqbal ve J.M. Walenga. “Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions”. Blood, 112, 4048, 2009, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source: medicana.com.tr profile page

  10. B23. Adiguzel, C., V. Bansal, J. Cunanan, E. Litinas, D. Hoppensteadt ve J. Fareed. “Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients Contributes to the Hemostatic Abnormalities”. Blood, 112, 4078, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source: medicana.com.tr profile page

  11. B24. Adiguzel, C., V. Bansal, J. Cunanan, E. Litinas, D. Hoppensteadt ve J. Fareed. “Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated Hemodynamic Responses”. Blood, 112, 4079, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008).

    Source: medicana.com.tr profile page

  12. B25. Fareed, J., O. Iqbal, D. Hoppensteadt, C. Adiguzel, M. Iacobelli ve J.M. Walenga. “Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight Heparins”. Blood, 112: 4086, 2008;. (50. ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

    Source: medicana.com.tr profile page

  13. B26. Adiguzel, C., D. Hoppensteadt, J. Cunanan, R. Bick, J. Walenga ve J. Fareed “Prevalence of heparin induced thrombocytopenia antibodies in cancer patients treated with a low molecular weight heparin”. J Clin Oncol (May 20 suppl) 26, abstr 20601, 2008, (2008 ASCO Annual Meeting, Chicago, USA).

    Source: medicana.com.tr profile page

  14. B27. Fareed, J., O. Iqbal, D. Fareed, D. Hoppensteadt, C. Adiguzel ve J. Cunanan “Upregulation of procalcitonin in cancer patients with venous thrombosis is independent of sepsis”. J Clin Oncol (May 20 suppl), 26, abstr 20583, 2008, (2008 ASCO Annual Meeting, Chicago, USA).

    Source: medicana.com.tr profile page

  15. B28. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan, W. Jeske, E.Ramacotti, M. Gomes, J. Fareed, J. Walenga,. “Distinct batches of branded parnaparins have differents HIT sera mediated platelet aggregation”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 93, 2008.

    Source: medicana.com.tr profile page

  16. B29. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan, W. Jeske, E.Ramacotti, M. Gomes ve J. Fareed. “Generic versions of LMWH can be differenciated in HIT sera mediated platelet aggregation”. XXIII World Congress of the International Union of Angiology, Athens, (Oral Presentation), 93, 2008.

    Source: medicana.com.tr profile page

  17. B30. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan, W. Jeske, E.Ramacotti, M. Gomes, K. Nelson ve J. Fareed. “The inhibition of microparticles generation, platelet aggregation and activation by enoxaparin”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 81, 2008.

    Source: medicana.com.tr profile page

  18. B31. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan, E.Ramacotti, M. Gomes, K. Nelson ve J. Fareed. “Danaparoid mediated inhibition of microparticles generation, platelet aggregation and P-selectin expression”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 81, 2008.

    Source: medicana.com.tr profile page

  19. B32. Ramacotti, E., M. Gomes, C. Adiguzel, A.Comerota, D. Hoppensteadt , A. Nicolaides ve J. Fareed. “An Open, Non-randomized, prospective clinical trial comparing the pharmacodynamics of two enoxaparins (Barnded- Sanofi-Aventis-SA and Generic Biochimico- Cutenox-CT), 40 mg o.d 6-14 days in acutely medically ill patients”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 82, 2008.

    Source: medicana.com.tr profile page

  20. B33. Gomes, M., E.Ramacotti, C. Adiguzel, A. Comerota, D. Hoppensteadt , A. Nicolaides ve J. Fareed. “An Open, Non-randomized, prospective clinical trial comparing the pharmacodynamics of two enoxaparins (Barnded- Sanofi-Aventis-SA and Generic Biochimico- Cutenox-CT), 40 mg o.d 10 days in healthy volunteers”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 81, 2008.

    Source: medicana.com.tr profile page

  21. B34. Walenga, J, V. Bansal, D. Hoppensteadt, C. Adiguzel, H. Messmore, R. Bick ve Jawed Fareed. “Decrease prevalance of antiheparin platelet factor 4 antibodies in end steage renel disease”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 68, 2008.

    Source: medicana.com.tr profile page

  22. B35. Clark M., D. Hoppensteadt , J. Cunanan, C. Adiguzel, R. Leinhardt ve J. Fareed. “Molecular profiling of a heparinase resistant glycosaminoglycan in contaminated heparins. Comparative studies with noncontaminated heparin and O-sulfonated chodroitin sulfate”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 65,2008.

    Source: medicana.com.tr profile page

  23. B36. Zhu, H., D. Hoppensteadt , J. Cunanan, C. Adiguzel, L. Bick ve J. Fareed. “Reduced immunogenic potential of membrane filtered bovine thrombine preparations for hemostatic application”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 27, 2008.

    Source: medicana.com.tr profile page

  24. B37. Clark, M., D. Hoppensteadt , J. Cunanan, C. Adiguzel, R. Leinhardt ve J. Fareed. “Comparative anticoagulant and antiprotease actions of O-sulfated chondroitin sulfate (OSCS), unfractionated heparin (UFH), and their mixtures”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 25, 2008.

    Source: medicana.com.tr profile page

  25. B38. Walenga, J., W. Jeske, D. Hoppensteadt, O. Iqbal, C. Adiguzel, H. Messmore ve J. Fareed. “Differential heparin-induced thrombocytopenic potential of low molecular weight heparins”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 25 , 2008.

    Source: medicana.com.tr profile page

  26. B39. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan ve J. Fareed. “Suledoxide mediated inhibition of tissue factor activation of platelet a potential mechanism for the observed therapeutic effects in diabetic nephropathy”. Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#4281, 2008.

    Source: medicana.com.tr profile page

  27. B40. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan ve J. Fareed. “Comparative anticoagulant effects of suledoxide and enoxaparin in citrated whole blood”. Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#2388, 2008.

    Source: medicana.com.tr profile page

  28. B41. Samiccannu, M.R., C. Adiguzel , O. Iqbal, D. Hoppensteadt , J. Cunanan ve J. Fareed. “The inhibition of microparticle generation by anticoagulant drugs”. Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#7073, 2008.

    Source: medicana.com.tr profile page

  29. B42. Hoppensteadt, D., V. Bansal, J. Cunanan, K. Patel, C. Adiguzel, R. Wahi ve J. Fareed. “Prevalence of non-specific cross-reactive epitopes to bovine factor VA light chain fragments in end stage renal disease, acute coronary syndrome and burn patient plasma”. Haemostaseologie (52. GTH Annual Meeting Abstracts), A 93, 2008.

    Source: medicana.com.tr profile page

  30. B43. Adiguzel, C., O. Iqbal, M. Sammikannu, J. Cunanan, W. Jeske, D. Hoppensteadt, ve J. Fareed. “Potency Adjusted Generic Versions of Argatroban Can Be Differentiated from Branded Argatroban in Thrombin Generation and Platelet Activation Assays”. Blood, 110, 4007, 2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source: medicana.com.tr profile page

  31. B44. Adiguzel, C., O. Iqbal, D. Fareed, D. Hoppensteadt, W. Jeske, M.Sammikannu ve J. Fareed. “Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications”. Blood; 110, 3898, 2007, (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source: medicana.com.tr profile page

  32. B45. Iqbal, O., C. Adiguzel, D. Hoppensteadt, J. Cunannan, ve J. Fareed. “Factor Xa Inhibitors Can Be Differentiated İn Xa, Iıa And Microparticle Generation And Other Whole Blood Based Assays”. Blood, 110, 931,2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source: medicana.com.tr profile page

  33. B46. Demir, M., A. Ciftci, D. Hoppensteadt, G. Altiay, M. Tobu, O. Iqbal, D. Fareed, C. Adiguzel, M. Kujawski ve J. Fareed. “ProteinChip Array Profiling and Markers of Inflammation and Thrombin Generation in Plasma Samples from Lung Cancer Patients and Their Modulation by Chemotherapy with or without Warfarin Anticoagulation”. Blood, 110, 3978, 2007, (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source: medicana.com.tr profile page

  34. B47. Kujawski, M.R, M. Prechel, H. Zhu, J. Walenga, D. Hoppensteadt, J. Cunanan, C. Adiguzel ve J. Fareed. “A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples”. Blood, 110, 3205, 2007, (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source: medicana.com.tr profile page

  35. B48. N. Fabbrini, D. Hoppensteadt, H. Messmore, R. Bick, C. Adiguzel ve J. Fareed. “Upregulation of Microparticles and CD40 Ligand in Antiphospholipid Syndrome: Potential Implication in Inflammatory Responses and Thrombosis”. Blood, 110, 1740, 2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

    Source: medicana.com.tr profile page

  36. B49. Adıgüzel C, Kaygusuz I, Birtaş Ateşoglu E, Noyan F, Çetiner M, Demiralp E, Fıratli-Tuğlular T, Bayık M. Chronic Myelogenous Leukemia occurring in mother and son. 1st International Lymphoma-Leukemia-Myeloma Congress, Abstract No:139, page 116, Fethiye/Muğla, 24-27 May 2007

    Source: medicana.com.tr profile page

  37. B50. Adıgüzel, C., S. Uyar-Bozkurt, T. Tecimer, E. Birtaş, I. Kaygusuz, F. Noyan, A. Uzay ve M. Bayık. “HHV-8 Negative Primary Effusion Lymphoma in a HIV Negative Patient” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.

    Source: medicana.com.tr profile page

  38. B51. Uzay, A., C. Adıgüzel, M. Demir, M. Bayık. “The in vitro Effect of Different Molecular Weight Hydroxyethyl Starch Solutions and Saline on Platelet Aggregation” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.

    Source: medicana.com.tr profile page

  39. B52. Noyan, F., E. Birtaş, C. Adıgüzel, I. Kaygusuz, M. Çetiner, , T. Fıratlı-Tuğlular ve M. Bayık, , “A VAD Therapy Resistant Multiple Myeloma Transformed From CLL” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.

    Source: medicana.com.tr profile page

  40. B53. Birtaş, E., Z. Odabaşı, T. Fıratlı-Tuğlular, C. Adıgüzel, I. Kaygusuz, F. Noyan, M. Çetiner, V. Korten ve M. Bayık. “Epidemiology of Bacterial Infections in Febrile Neutropenic Patients Having Hematological Malignancies in Marmara University Hospital, İstanbul, Turkiye” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.

    Source: medicana.com.tr profile page

  41. B54. Eksioglu-Demiralp,E., P. Bizargity, C. Adiguzel, G. Ozilhan ve M. Bayik. “Imatinib Does Not Inhibit Neutrophil Oxidative Burst Function in Patients with Chronic Myelogenous Leukemia (CML)”. The American Society of Hematology 46th Annual Meeting and Exposition, December 9-12, USA. , Blood (ASH Annual Meeting Abstracts, 104: Abstract 4673 ) 2004

    Source: medicana.com.tr profile page

  42. B55. Çetiner, M., S. Kalaça, S. Ratip, Ç. Yazgan, C. Adıgüzel, S. Kalayoğlu-Beşışık, D. Argon, I. Kaygusuz, G. Aktuğlu ve M. Bayık, “Quality of Life Assessment of Haematopoietic Stem cell Transplantationpatients in İstanbul: a Pilot Study,” 30th Annual Meeting of the European Group for Blood and Marrow Transplantation, Barcelona, Bone Marrow Transplantation, Vol. XXXIII, 2004

    Source: medicana.com.tr profile page

  43. B56. Adıgüzel, C., M. Sönmezoğlu, D. Argon, T. Akdeniz, E.Z. Demiralp ve M. Bayık. “Effects of irradiation and filtration on viability of platelets”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, pg24, 5-9 Temmuz 2003.

    Source: medicana.com.tr profile page

  44. B57. Yüksel, M., D. Argon, C. Adıgüzel, M. Sönmezoğlu, M. Bayık ve S. Yalçın. “Effects of gamma irradiation and storage on apheresis platelets: The role of reactive oxygen species”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, 5-9 Temmuz 2003, pg 5

    Source: medicana.com.tr profile page

  45. B58. Sönmezoğlu, M., D. Argon, C. Adıgüzel ve M. Bayık. “Evaluation of storage conditions of blood bank by measuring of free hemoglobin in red cell concentrates and whole blood”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, pg55, 5-9 Temmuz 2003.

    Source: medicana.com.tr profile page

  46. B59. Argon, D., M. Sönmezoğlu, C. Adıgüzel ve M. Bayık. “Effects of prestorage leukocyte depletion on the platelet storage lesion”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, 5-9 Temmuz 2003, pg55

    Source: medicana.com.tr profile page

  47. B60. Kartı, S.S., S. Ratip, M. Yılmaz, S. Ukınç, A. Örem, C. Adıgüzel, F. Dane, N. Kandemir, E. Ovalı ve M. Bayık. “Therapeutic Trial of Cobalamin in Patients with Normal Serum Cobalamin Levels and Predicted Cobalamin Deficiency”. 7 th Meeting of the European Hematology Association, Florence, İtaly, The Hematology Journal suppl., Vol. 3. 2002.

    Source: medicana.com.tr profile page

  48. D1. Birtaş-Ateşoğlu, E., T.Fıratlı-Tuğlular, C. Adıgüzel, I. Kaygusuz, F. Noyan, M. Çetiner, M. Bayık. “A case of Cauda Equina syndrome in a leukemic patient due to intrathecal methotrexate”, Tr J Haematol, 24, 28-31 (2007)

    Source: medicana.com.tr profile page

  49. D2.Kaygusuz, I., Z. Odabaşı, C. Adıgüzel, F. Noyan, E. Birtaş, V. Korten, T. Fıratlı-Tuğlular, M. Çetiner, M Bayık. “Complete heart block in a neutropenic patient with invasive aspergillosis”, Tr J Haematol, 23, 205-208 (2006)

    Source: medicana.com.tr profile page

  50. D3.Çetiner, M., T. Fıratlı-Tuğlular, Y. Özen-Al Ahdab, H. Al Ahdab, M. Köse, F. Noyan, C. Adıgüzel, E. Ovalı, M. Bayık. “Amifostine treatment in patients with myelodysplastic syndrome” Turk J Haematol, 22, 117-123 (2005)

    Source: medicana.com.tr profile page